Related Experiment Videos
PHF3 expression is frequently reduced in glioma
U Fischer1, A K Struss, D Hemmer
1Institut für Humangenetik, Universität des Saarlandes, Homburg/Saar, Germany.
Cytogenetics and Cell Genetics
|February 22, 2002
Summary
Researchers identified PHF3, a novel gene crucial for brain tumor development. Loss of PHF3 expression is linked to glioblastoma and other astrocytic tumors, suggesting its role in glioma progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioblastoma is the most prevalent and aggressive primary brain tumor.
- Identifying genes involved in glioblastoma development is crucial for understanding its pathogenesis.
- Previous research identified chromosome alterations but few specific genes linked to glioblastoma pathways.
Purpose of the Study:
- To identify novel genes implicated in glioblastoma development.
- To characterize the expression pattern of a newly identified gene, PHF3, in normal and tumor tissues.
Main Methods:
- Combined immunological and molecular screening approaches were employed.
- Expression analysis of the PHF3 gene was performed in various brain tumor types and normal tissues.
- Bioinformatic analysis was used to predict the functional domains and homology of the PHF3 protein.
Main Results:
- A novel gene, PHF3, located on human chromosome 6q12, was identified.
- PHF3 is ubiquitously expressed in normal tissues but significantly reduced or lost in glioblastoma, anaplastic astrocytomas, and astrocytomas.
- PHF3 protein contains transcription factor motifs, including a PHD finger (LAP motif) and homology to TFIIS, suggesting regulatory functions.
Conclusions:
- PHF3 is a novel gene belonging to a family of regulatory proteins with a LAP motif.
- Reduced or lost PHF3 expression in glioblastoma may contribute to the development and progression of gliomas.
- PHF3 represents a potential target for future therapeutic strategies against brain tumors.